VANCOUVER, BC – Kapoose Creek Bio is delighted to announce the appointment of Dr. Stewart Fisher to its Board of Directors. Globally recognized as a trailblazer in drug discovery and… Read More
VANCOUVER, BC – ARC Medical Inc., a clinical stage medical device company focused on advancing surgical adhesion prevention, announced that three scientific abstracts highlighting one of its lead medical devices,… Read More
Scemblix® is first to show superior efficacy and a favourable safety and tolerability profile in a Phase III trial vs. all standard of care (SoC) therapies Fifty percent of CML… Read More
Final CDA recommendation reflects the urgent unmet need in a progressive, life-limiting condition and recognizes the value of a therapy that slows disease progression Regional differences in disease burden make… Read More
DURECT’s lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation Potential to be the first FDA-approved therapeutic option for the treatment of patients with alcoholic hepatitis Proposed… Read More
